Corneal Regional Business Managers | San Francisco, CA

launched our first MIGS device-the i Stent®-in the United States, followed by our next-generation i Stent inject® device in September 2018. In November 2019, Glaukos acquired Avedro, maker of the first and only FDA-approved cross-linking technology for progressive keratoconus.

And we continue to seek to leverage our platform technologies to build a comprehensive and proprietary portfolio of micro-scale surgical and medical therapies for glaucoma, corneal health, and retinal diseases. Our company completed an initial public offering in June of 2015, and our shares are traded on the New York Stock Exchange under the ticker symbol " GKOS" Our global headquarters is located in Aliso

Viejo, California with additional locations in San Clemente, California and Burlington, Massachusetts. How will you make an impact? The Sr. Corneal Health Sales Manager responsibilities include developing key growth sales strategies, business development tactics and action plans.

Successful execution of these strategies is required to achieve the financial targets. The Corneal Health Sales Manager duties will include hitting annual equipment & procedural targets, building relationships and understanding customer trends driving results while adhering to the company's values of integrity, mutual respect, accountability and commitment to quality. This position will report to the Area Director

and collaborate with other Sr. Regional Business Manager counterparts to achieve commercial objectives.

What will you do? Deliver or exceed annual sales targetswith defined sales territory and account base Develop and execute strategic business development plan to achieve sales targets, increase procedural utilization and expand our customer base Build and maintain strong, long-lasting customer relationships at all levels within practices Partner with customers to understand their business needs and objectives Collaborate, partner & lead local sales representatives, field reimbursement, marketing, field service and clinical support to ensure commercial success Effectivelycommunicate the business value proposition and financial feasibility for capital equipment sales process through proposals/presentation at physician, executive, administrator level Project manager for practices on integration of Corneal Cross Linking (CXL) procedure (from patient education, clinical workflow, billing process, marketing, etc.

) Understand category-specific landscapes and trends Report on forces that shift tactical budgets and strategic direction of accounts Educate staff on clinical workflow and support procedures as needed Engage, educate, motivate staff from technicians to billing department Interact with Marketing Director/Optometric outreach, administrators and develop CXL marketing strategy, deploy resources and drive OD education Identify OD and MD referral opportunities around CXL centers and influence referral patterns Cohesively work, communicate with the Glaukos RBM peers and other Glaukos departments How will you get here?

Bachelor's degree required 5+ years proven track record in sales performance in the medical device industry Minimum 3 years Ophthalmic Medical Device, Surgical Device or medical sales experience Proven sales executive experience, meeting or exceeding targets Ability to travel 2-3 nights per week and manage multi-city or multi-state geography Previous experience as a sales executive, sales manager or sales & marketing manager Proven ability to drive the sales process from plan to completion to ongoing customer support with incremental business growth Proven ability to articulate the distinct value of products, procedures and services against other competitive and non-competitive products Generous.

Innovative. Leadership-driven. Family-oriented. Socially responsible. These are just a few of the terms our employees use to describe their experiences as a part of the Glaukos family.

Those may seem like big aspirations, but here at Glaukos, we recognize the deep significance and profound meaning that comes from knowing that we can make a meaningful difference by helping improve eyesight of people worldwide. And because we're a rapidly growing company with a dynamic, fast-paced culture, individual employees are empowered with more diverse and enriching challenges that might not be possible at a larger company, and more fulfillment in knowing every person and every task is directly tied to making a difference in the life of others.

We offer competitive salary (based on experience), bonus eligibility, medical/dental/vision, life insurance, stock options, 401(k) Employer Match, Employee Stock Purchase Program, generous time off & paid holidays as well as time-off to volunteer in the community, plus the opportunity to work for a company that is pioneering a new glaucoma treatment class! Moreover, Glaukos Corporation has been Certified as a Great Place to Work the last three years! Glaukos Corporation is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, interaction including interactionual orientation and gender identity, national origin, disability, protected Veteran Status, or any other characteristic protected by applicable federal, state, or local law.

ABOUT US Founded in 1998, Glaukos Corporation is an ophthalmic medical technology and medical company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. Our company was the first company to bring to market Micro-Invasive Glaucoma Surgery (MIGS), the micro-invasive procedure which revolutionized the treatment and management of glaucoma.

In 2012, we launched our first MIGS device-the i Stent®-in the United States, followed by our next-generation i Stent inject® device in September 2018 and i Stent inject® W in September 2020. In November 2019, Glaukos acquired Avedro, maker of the first and only FDA-approved cross-linking technology for progressive keratoconus. And we continue to seek to leverage our platform technologies to build a comprehensive and proprietary portfolio of micro-scale surgical and medical therapies for glaucoma, corneal health, and retinal diseases.

Our company completed an initial public offering in June of 2015, and our shares are traded on the New York Stock Exchange under the ticker symbol " GKOS" Our global headquarters is located in San Clemente, California with additional locations in Waltham and Burlington, Massachusetts. Glaukos Corporation is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employmentwithout regard to race, color, religion, interaction including interactionual orientation and genderidentity, national origin, disability, protected Veteran Status, or any othercharacteristic protected by applicable federal, state, or local law.